Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has earned a consensus recommendation of “Hold” from the fifteen analysts that are currently covering the firm, Marketbeat reports. Two equities ...

Chu's Wicked is now the most-streamed movie for the week of March 17-23, 2025 with 882 million minutes viewed in its first ...

In terms of liquidity and interest, the mean open interest for Hims & Hers Health options trades today is 1566.44 with a ...

Though estimates vary, some research suggests that up to 30 percent of men experience symptoms of PE at one point in life or ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...

Learn more about whether Hims & Hers Health, Inc. or LifeStance Health Group, Inc. is a better investment based on AAII's A+ ...

Learn more about whether Alignment Healthcare, Inc. or Hims & Hers Health, Inc. is a better investment based on AAII's A+ ...

What's the Most Popular Love Language in America? Hims asked Americans which of the following best describes their love ...

While swiping left and right have become synonymous with dating culture among younger generations, a 2025 Hims study found ...

A study of a woman who died in 2024 as the oldest person on Earth attempts to untangle the factors that enable some people to ward off disease in old age. Why did Hatshepsut have her husband buried to ...

The knockoff surge was led by Hims & Hers Health, the telehealth firm that began selling the drugs last spring.